duocarmycin sa has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hudson, R; Patel, D; Suthe, SR; Wang, MH; Yao, HP | 1 |
| Lee, M; Patil, PC; Satam, V | 1 |
| Alves, F; Schmuck, K; Schuberth, I; Schuster, HJ; Tietze, LF | 1 |
| Alves, F; Krewer, B; Major, F; Müller, M; Schuberth, I; Schuster, HJ; Tietze, LF; von Hof, JM | 1 |
| Krewer, B; Schuberth, I; Schuster, HJ; Tietze, LF | 1 |
| Krewer, B; Tietze, LF | 1 |
| Major, F; Schuberth, I; Tietze, LF | 1 |
1 review(s) available for duocarmycin sa and Neoplasms
| Article | Year |
|---|---|
A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Proliferation; DNA Methylation; DNA, Neoplasm; Duocarmycins; Humans; Indoles; Molecular Structure; Neoplasms; Pyrroles | 2015 |
6 other study(ies) available for duocarmycin sa and Neoplasms
| Article | Year |
|---|---|
Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase.
Topics: Animals; Body Weight; Cell Line, Tumor; Duocarmycins; Humans; Immunoconjugates; Mice; Neoplasms; Proto-Oncogene Proteins c-met; Xenograft Model Antitumor Assays | 2022 |
Duocarmycin-based prodrugs for cancer prodrug monotherapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Duocarmycins; Glucuronates; Glucuronic Acid; Humans; Indoles; Inhibitory Concentration 50; Neoplasms; Prodrugs; Pyrroles | 2008 |
Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.
Topics: Antineoplastic Agents; beta-Galactosidase; Cell Line, Tumor; Duocarmycins; Glycosides; Humans; Indoles; Inhibitory Concentration 50; Neoplasms; Prodrugs; Pyrroles; Stereoisomerism | 2008 |
Synthesis and biological studies of different duocarmycin based glycosidic prodrugs for their use in the antibody-directed enzyme prodrug therapy.
Topics: Antibodies; beta-Galactosidase; Chromatography, High Pressure Liquid; Duocarmycins; Glycosides; Indoles; Magnetic Resonance Spectroscopy; Neoplasms; Prodrugs; Pyrroles; Spectrometry, Mass, Electrospray Ionization | 2009 |
Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; beta-Galactosidase; Cell Line, Tumor; Drug Design; Duocarmycins; Glycosides; Humans; Indoles; Neoplasms; Prodrugs; Pyrroles; Stereoisomerism | 2009 |
Antitumor agents: development of highly potent glycosidic duocarmycin analogues for selective cancer therapy.
Topics: Alkylating Agents; Antibodies; Cell Line, Tumor; Drug Delivery Systems; Duocarmycins; Humans; Indoles; Neoplasms; Prodrugs; Pyrroles; Streptomyces; Tumor Stem Cell Assay | 2006 |